We examined multiple samples of 65 primary breast carcinomas larger than I cm in diameter for thymidine labelling index (TLI), DNA index (DNAI, a measure of cellular DNA content by flow cytometry), and estrogen (ER) and progesterone (PgR) receptors by radioligand-binding. One or more axillary metast
DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients
β Scribed by Charlotte R. Wenger; Susan Beardslee; Marilyn A. Owens; George Pounds; Teri Oldaker; Patricia Vendely; M. R. Pandian; Douglas Harrington; Gary M. Clark; William L. McGuire
- Publisher
- Springer US
- Year
- 1993
- Tongue
- English
- Weight
- 1002 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## SOUTH-EAST SWEDEN BREAST CANCER GROUP' Cellular DNA content was analyzed by flow cytometry and estrogen and progesterone receptors by an immuno-biochemical method (EIA) in a consecutive series of 807 frozen breastcancer samples. Before the beginning of the study, a mammography screening program
In this prospective study, the independent prognostic value of DNA ploidy in combination with the major clinico-pathological characteristics (histological grade, nodal status, tumor size, estrogen and progesterone receptor status, number of tumors, multicentricity, lympho-vascular infiltration) was